9.33% 0.965

Phathom Pharmaceuticals Inc (PHAT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Phathom Pharmaceuticals Inc-Aktie (PHAT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	38.51% 39.50	28.52	29.66	16.35	7.324
Cost Of Revenue	35.28% 5.038	3.724	3.815	2.356	1.376
Gross Profit	39.00% 34.47	24.80	25.85	14.00	5.948
Operating Expenses	8.94% 94.39	103.66	85.27	84.79	83.25
Benefits Costs and Expenses	100.00% -	122.83	104.11	-	-
Costs And Expenses	19.06% 99.43	122.83	104.11	87.15	84.62
Operating Income/Loss	24.02% -59.92	-78.86	-59.42	-70.80	-77.30
Nonoperating Income/Loss	2.80% -15.89	-15.45	-15.03	-14.78	-14.15
Income/Loss From Continuing Operations Before Tax	141.88% 39.50	-94.32	-74.45	16.35	-91.45
Income/Loss From Continuing Operations After Tax	19.62% -75.81	-94.32	-74.45	-85.58	-91.45
Net Income/Loss	19.62% -75.81	-94.32	-74.45	-85.58	-91.45
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.69% 72.47	71.97	2.6327	64.63	58.56
Diluted Average Shares	0.69% 72.47	71.97	2.6327	64.63	58.56
Basic Earnings Per Share	19.85% -1.05	-1.31	-1.00	-1.32	-1.56
Diluted Earnings Per Share	19.85% -1.05	-1.31	-1.00	-1.32	-1.56
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

GMAB

$24.48

0.68%

INCY

$83.82

1.10%

SMMT

$26.78

1.85%

BNTX

$103.94

1.02%

INSM

$131.19

2.22%

ONC

$307.29

0.42%